KPV: Mechanistic Overview
internal_protocolpreclinical · status: needs_provider_reviewDetails
Author: Axiom Knowledge Base
Citation: Internal reference summary compiled for the Axiom knowledge base (2026).
File: signed link
Summary (generated — provider review required)
KPV is a tripeptide derived from the C-terminus of alpha-melanocyte-stimulating hormone (alpha-MSH). Mechanism: anti-inflammatory effects, including downregulation of NF-kB signaling and pro-inflammatory cytokines, studied in models of gut and skin inflammation. Relevance: interest in gut-barrier and inflammatory/mast-cell contexts.
The original source document remains the source of truth. Generated summaries are not authoritative.
Linked assets (4) · phenotypes (0)
evidence_reference, mechanism, safety_reference, dosing_reference
Findings (3) · awaiting review (2)
mechanism · pending
Mechanism: anti-inflammatory effects, including downregulation of NF-kB signaling and pro-inflammatory cytokines, studied in models of gut and skin inflammation.
safety · pending
Safety: human evidence limited; regulatory status varies.
dosing · pending
Mechanistic background for provider review only — not a treatment recommendation or dosing guidance.
Processing
Processed into 1 searchable section.